Abstract
Urinary tract infections (UTI) comprise an important group of clinical syndromes that are classified as either uncomplicated or complicated, according to their presentation or response to therapy and the presence of underlying risk factors. UTI can be further divided into relatively distinct clinical entities that include acute uncomplicated UTI in women, acute uncomplicated pyelonephritis, complicated UTI and UTI in men, asymptomatic bacteruria, and recurrent UTI. This chapter will focus primarily on the syndrome of uncomplicated UTI in women, which makes up by far the largest single category of UTI seen by physicians in practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abraham SN, et al: Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors. Infect Immun, 48:625, 1985.
Arav-Boger, Leibovici RL, Danon YL: Urinary tract infections with low and high colony counts in young women: Spontaneous remission and single-dose vs. multiple-day treatment. Arch Int Med, 154:300, 1994.
Barnett BJ, Stephens DS: Urinary tract infections: an overview. Am J Med Sci, 314:245, 1997.
Choudhury D, Thompson A, Stojanoff V, Langermann S, Pinkner J, Hultgren SJ, et al: X-ray Structure of the FimC-FimH Chaperone-Adhesin Complex from Uropathogenic Escherichia coli. Science, 285:1061, 1999.
Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science, 284(5418):1318, 1999.
De Donato S, Granoff D, Minutello M, Lecchi G, Faccini M, Agnello M, et al: Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly. Vaccine, 17:3094, 1999.
Delzell JE, Lefevre ML: Urinary tract infections during pregnancy. Am Fam Physician, 61:713, 2000.
Dodson K, Jacob-Dubuisson F, Striker RT, Hultgren SJ: Outer-membrane PapC molecular usher discriminately recognizes periplasmic chaperone-pilus subunit complexes. Proc Natl Acad Sci USA, 90:3670, 1996.
Elo J, Tallgren LG, Vaisanen V, Korhonen TK, Svenson SB, Makela PH: Association of P and other fimbriae with clinical pyelonephritis in children. Scand J Urol Nephrol, 19:281, 1985.
Gupta K, Scholes D, Stamm WE: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA, 281:736, 1999.
Hanson MS, Brinton CC: Identification and characterization of E. coli type-1 pilus tip adhesion protein. Nature, 332:265, 1988.
Hooton TM, Scholes D, Hughes J, Winter C, Roberts P, Stapleton A, et al: A prospective study of risk factors for symptomatic urinary tract infection in young women. New Engl J Med, 335:468, 1996.
Hultgren SJ, Abraham S, Caparon M, Falk P, St Geme III JW, Normark S: Pilus and nonpilus bacterial adhesins: assembly and function in cell recognition. Cell, 73:887, 1993.
Hultgren SJ, Normark S, Abraham SN: Chaperone-assisted assembly and molecular architecture of adhesive pili. Annu Rev Microbiol, 45:383, 1991.
Hultgren SJ, Schwan WR, Schaeffer AY, Duncan JL: Regulation of Production of Type 1 Pili Among Urinary Tract Isolates of Escherichia coli. Infect Immun, 54:613, 1986.
Hung DL, Hultgren SJ: Pilus biogenesis via the chaperone/usher pathway: an integration of structure and function. J Struct Biol, 124(2–3):201, 1998.
Hung DL, Knight SD, Woods RM, Pinkner JS, Hultgren SJ: Molecular basis of two subfanilies of immunoglobulin-like chaperones. EMBO J, 15:379, 1996.
Jacob-Dubuisson F, Kuehn M, Hultgren SJ: A novel secretion apparatus for the assembly of adhesive bacterial pili. Trends in Microbiol, 1:50, 1993.
Johnson JR, Stamm WE: Diagnosis and treatment of urinary tract infections. Infect Dis Clin North Am, 1:773, 1987.
Johnson JR, Stamm WE: Urinary tract infections in women: diagnosis and treatment. Ann Int Med, 111:906, 1989.
Jones CH, Pinkner JS, Nicholes AV, Slonim LN, Abraham SN, Hultgren SJ, et al: FimC is a periplasmic PapD-like chaperone that directs assembly of type 1 pili in bacteria. Proc Natl Acad Sci USA, 90:8397, 1993.
Jones CH, Pinkner JS, Roth R, Heuser J, Nicholes AV, Abraham SN, et al: FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriacae. Proc Natl Acad Sci, 92:2081, 1995.
Kallenius G, Svenson SB, Hultberg H, Mollby R, Helin I, Cedergen B, et al: Occurrence of P-fimbriated Escherichia coli in urinary tract infection. Lancet, II: 1369, 1981.
Kass EH: Bacteruria and the diagnosis of infection of the urinary tract, with observations on the use of methionine as a urinary antiseptic. Arch Intern Med, 100:709, 1957.
Kass EH, Finland M: Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians, 69:56, 1956.
Kisielius PV, Schwan WR, Amundsen SK, Duncan JL, Schaeffer AJ, et al: In vivo Expression and Variation of Escherichia coli Type 1 and P Pili in the Urine of Adults With Acute Urinary Tract Infections. Infect Immun, 57:1656, 1989.
Kuehn MJ, Heuser J, Normark S, Hultgren SJ: P Pil in uropathogenic E. coli are composite fibres with distinct fibrillar adhesive tips. Nature, 356:252, 1992.
Kuehn MJ, Normark S, Hultgren SJ: Immunoglobulin-like PapD chaperone caps and uncaps interactive surfaces of nascently translocated pilus subunits. Proc Natl Acad Sci USA, 88(23):10586, 1991.
Kunin CM: Urinary tract infections in females. Clin Infect Dis, 18:1, 1994.
Langermann S, Mollby R, Burlein JE, Palaszynski SR, Auguste CG, DeFusco A, et al: Vaccination with FimH Adhesin Protects Cynomolgus Monkeys from Colonization and Infection by Uropathogenic Escherichia coli. J Infect Dis, 181:774, 2000.
Langermann S, Palazynski S, Barnhart M, Auguste G, Pinkner J, Burlein J, et al: Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science, 276:607, 1997.
Li H, Walker DH: Characterization of Rickettsial Attachment to Host Cells by Flow Cytometry. Infect Immu., 60:2030, 1992.
Minutello M, Senatore F, Cecchinelli G, Bianchi M, Andreani T, Podda A, et al: Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons. Vaccine, 17(2):99, 1999.
Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, et al: Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science, 282:1494, 1998.
Ofek I, Mosek A, Sharon N, et al: Mannose-specific adherence of Escherichia coli freshly excreted in the urine of patients with acute urinary tract infections and of isolates subcultured from the infected urine. Infect Imm, 34:708, 1981.
O’Hanley P, Lark D, Falkow S, Schoolnik G: Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. J Clin Invest, 75:347, 1985.
Roberts JA: Contribution of experimental pathology to the understanding of human pyelonephritis. J Urol, 148:1721, 1992.
Roberts JA: Vesicoureteral reflux and pyelonephritis in the monkey: a review. Urol., 148:1721, 1992.
Roberts JA, Marklund BI, Ilver D, Haslam D, Kaack MB, Baskin G, et al: The Gal(alpha l-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc Natl Acad Sci USA, 91:11889, 1994.
Sauer FG, Fütterer K, Pinkner JS, Dodson KW, Hultgren SJ, Waksman G: Structural Basis of Chaperone Function and Pilus Biogenesis. Science, 285:1058, 1999.
Saulino ET, Thanassi DG, Pinkner J, Hultgren SJ: Ramifications of kinetic partitioning on usher-mediated pilus biogenesis. EMBO J, 17(8):2177, 1998.
Stamey TA, Sexton CC: The role of vaginal colonization with Enterobacteriaceae in recurrent urinary tract infections. J Urol, 113:214, 1975.
Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK: Diagnosis of coliform infection in acutely dysuric women. N Eng J Med, 307:463, 1982.
Thanassi DG, Saulino ET, Hultgren SJ: The chaperone/usher pathway: a major terminal branch of the general secretory pathway. Curr Opin Microbiol, 1:223, 1998.
Thanassi DG, Saulino ET, Lombardo MJ, Roth R, Heuser J, Hultgren SJ: The PapC usher forms an oligomeric channel: implications for pilus biogenesis across the outer membrane. Proc Natl Acad Sci USA, 95(6):3146, 1998.
Vaisanen V, Tallgren L, Makela P, et al: Mannose Resistant Hemagglutination and P Antigen Recognition Are Characteristics of Escherichia coli Causing Primary Pyelonephritis. Lancet, 2:1366, 1981.
Wu X-R, Sun T-T, Medina JJ: In vitro binding of type 1-fimbriated Escherichia coli to uroplakins la and lb: relation to urinary tract infections. Proc Natl Acad Sci USA, 93:9630, 1996.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Langermann, S., Ballou, W.R. (2003). Development of a Recombinant FIMCH Vaccine for Urinary Tract Infections. In: Atala, A., Slade, D. (eds) Bladder Disease, Part A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8889-8_41
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8889-8_41
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4707-1
Online ISBN: 978-1-4419-8889-8
eBook Packages: Springer Book Archive